SCHEMBL14911164

SCHEMBL14911164

CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Oc4ccnc(C(=O)NC)c4)cc3F)c(F)c2)ccn1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 6/20 0.73
RAF1 P04049 10/20 0.72
KDR P35968 8/20 0.72
MAPK14 Q16539 6/20 0.72
BRAF P15056 5/20 0.72
RET P07949 4/20 0.72
MAP3K20 Q9NYL2 4/20 0.72
EPHX2 P34913 4/20 0.72
RIPK2 O43353 3/20 0.72
KIT P10721 3/20 0.72
FGFR1 P11362 3/20 0.72
PDGFRA P16234 3/20 0.72
FLT1 P17948 3/20 0.72
EPHA1 P21709 3/20 0.72
TTK P33981 3/20 0.72
FLT4 P35916 3/20 0.72
FLT3 P36888 3/20 0.72
CLK1 P49759 3/20 0.72
LIMK1 P53667 3/20 0.72
CDK17 Q00537 3/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19888749 0.94 ABL1 (0.67) ABL1RAF1KDRMAPK14BRAF
SCHEMBL19888733 0.92 ABL1 (0.65) ABL1RAF1KDRMAPK14BRAF
SCHEMBL19878466 0.92 RAF1 (0.72) ABL1RAF1KDRMAPK14BRAF
SCHEMBL19888732 0.92 RIPK2 (0.70) ABL1RAF1KDRMAPK14BRAF
SCHEMBL19888717 0.92 ABL1 (0.65) ABL1RAF1KDRMAPK14BRAF
SCHEMBL14923005 0.92 ABL1 (0.63) ABL1RAF1KDRMAPK14BRAF
SCHEMBL10105554 0.92 ABL1 (0.67) ABL1RAF1KDRMAPK14BRAF
SCHEMBL1660178 0.92 RAF1 (0.68) ABL1RAF1KDRMAPK14BRAF
SCHEMBL1660412 0.91 ABL1 (0.63) ABL1RAF1KDRMAPK14BRAF
SCHEMBL19888727 0.91 RAF1 (0.75) ABL1RAF1KDRMAPK14BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10822305-B2 Process for the preparation of 4-(4-amino-3-fluorophenoxy)-N-methylpyyridine-2-carboxamide BAYER HEALTHCARE LLC (US) 2020-11-03 US disclosed
US-20190144391-A1 Process for the Preparation of 4-(4-amino-3-fluorophenoxy)-N-methylpyyridine-2-carboxamide BAYER HEALTHCARE LLC (US) 2019-05-16 US disclosed
US-20170334857-A1 Method of Purifying and using 4-chloro-n-methy1-2-pyridinecarboxamide BAYER HEALTHCARE LLC (US) 2017-11-23 US disclosed
US-20170247331-A1 PROCESS FOR THE PREPARATION OF 4-[-(AMINO)-3-FLUOROPHENOXY]-N-METHYLPYRIDINE-2-CARBOXAMIDE AND ITS POLYMORPHS THEREOF MSN LABORATORIES PRIVATE LIMITED (IN) 2017-08-31 US disclosed
US-20170247331-A1 PROCESS FOR THE PREPARATION OF 4-[-(AMINO)-3-FLUOROPHENOXY]-N-METHYLPYRIDINE-2-CARBOXAMIDE AND ITS POLYMORPHS THEREOF MSN LABORATORIES PRIVATE LIMITED (IN) 2017-08-31 US disclosed
US-20170247331-A1 PROCESS FOR THE PREPARATION OF 4-[-(AMINO)-3-FLUOROPHENOXY]-N-METHYLPYRIDINE-2-CARBOXAMIDE AND ITS POLYMORPHS THEREOF MSN LABORATORIES PRIVATE LIMITED (IN) 2017-08-31 US disclosed
US-20170057918-A1 PROCESS FOR THE PREPARATION OF 4-CARBONYL)AMINO]-3-FLUOROPHENOXY}-N-ETHYLPYRIDINE-2-CARBOXAMIDE, ITS SALTS AND MONOHYDRATE BAYER INTELLECTUAL PROPERTY GMBH (DE) 2017-03-02 US disclosed
US-9458107-B2 Process for the preparation of 4-{4-[({[4 chloro-3-(trifluoromethyl)-phenyl]amino}carbonyl)amino]-3-fluorphenoxy-N-ethylpyridie-carboxamide, its salts and monohydrate BAYER INTELLECTUAL PROPERTY GMBH (DE) 2016-10-04 US disclosed
WO-2016051422-A2 PROCESS FOR THE PREPARATION OF 4-[4-({[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]CARBAMOYL}AMINO)-3-FLUOROPHENOXY]-N-METHYLPYRIDINE-2-CARBOXAMIDE AND ITS POLYMORPHS THEREOF MSN LABORATORIES PRIVATE LIMITED (IN) 2016-04-07 WO disclosed
EP-2558448-B1 PROCESS FOR THE PREPARATION OF 4-{4-[({[4-CHLORO-3-(TRIFLUOROMETHYL)-PHENYL]AMINO}CARBONYL)AMINO]-3-FLUOROPHENOXY}-N-METHYLPYRIDINE-2-CARBOXAMIDE, ITS SALTS AND MONOHYDRATE BAYER HEALTHCARE LLC (US) 2015-05-20 EP disclosed
US-20140221661-A1 PROCESS FOR THE PREPARATION OF 4-CARBONYL)AMINO]-3-FLUOROPHENOXY}-N-ETHYLPYRIDINE-2-CARBOXAMIDE, ITS SALTS AND MONOHYDRATE BAYER INTELLECTUAL PROPERTY GMBH (DE) 2014-08-07 US disclosed
US-8748622-B2 Process for the preparation of 4-{4[({[4-chloro-3-(trifluoromethyl)-phenyl]amino}carbonyl)amino]-3-fluorophenoxy}-N-methylpyridine-2-carboxamide, its salts and monohydrate BAYER INTELLECTUAL PROPERTY GMBH (DE) 2014-06-10 US disclosed
US-20130116442-A1 PROCESS FOR THE PREPARATION OF 4-CARBONYL)AMINO]-3-FLUOROPHENOXY}-N-METHYLPYRIDINE-2-CARBOXAMIDE, ITS SALTS AND MONOHYDRATE BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-05-09 US disclosed
US-7910059-B2 For the determination of an analyte or analytes such as proteins, peptides, nucleic acids, carbohydrates, lipids, steroids and small molecules by mass analysis DH TECHNOLOGIES PTE. LTD. (SG) 2011-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190144391-A1 Process for the Preparation of 4-(4-amino-3-fluorophenoxy)-N-methylpyyridine-2-carboxamide DNPEP, NPEPPS, TET3 ABL1 24/4885RAF1 3657/4885KDR 2897/4885
US-20170334857-A1 Method of Purifying and using 4-chloro-n-methy1-2-pyridinecarboxamide TET2, NPEPPS, METAP1 ABL1 72/4885RAF1 4029/4885KDR 3758/4885
US-20170247331-A1 PROCESS FOR THE PREPARATION OF 4-[-(AMINO)-3-FLUOROPHENOXY]-N-METHYLPYRIDINE-2-CARBOXAMIDE AND ITS POLYMORPHS THEREOF CYP3A4, CYP4F2, CYP4B1 ABL1 403/4885RAF1 2861/4885KDR 3769/4885
US-20140221661-A1 PROCESS FOR THE PREPARATION OF 4-CARBONYL)AMINO]-3-FLUOROPHENOXY}-N-ETHYLPYRIDINE-2-CARBOXAMIDE, ITS SALTS AND MONOHYDRATE ACMSD, DNPEP, CPS1 ABL1 32/4885RAF1 2344/4885KDR 2111/4885
US-20170057918-A1 PROCESS FOR THE PREPARATION OF 4-CARBONYL)AMINO]-3-FLUOROPHENOXY}-N-ETHYLPYRIDINE-2-CARBOXAMIDE, ITS SALTS AND MONOHYDRATE ACMSD, DNPEP, CPS1 ABL1 32/4885RAF1 2345/4885KDR 2052/4885
US-20130116442-A1 PROCESS FOR THE PREPARATION OF 4-CARBONYL)AMINO]-3-FLUOROPHENOXY}-N-METHYLPYRIDINE-2-CARBOXAMIDE, ITS SALTS AND MONOHYDRATE ACMSD, DNPEP, CPS1 ABL1 34/4885RAF1 2574/4885KDR 2454/4885
US-10822305-B2 Process for the preparation of 4-(4-amino-3-fluorophenoxy)-N-methylpyyridine-2-carboxamide DNPEP, NPEPPS, TET3 ABL1 22/4885RAF1 3629/4885KDR 2813/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.